Phase 2b/3 data promising with new renin inhibitor in hypertension Nov 21, 2008 Data from a randomized clinical trial of the renin inhibitor—called SPP100 or aliskerin—were disclosed January 20, 2005, during a report of
ACP: ObserverWeekly - 13 March 2007 Mar 13, 2007 Clinical news. ACP Journal Club: Discontinuation of medications one month after MI raises death risk in 12 months. A new trial found that
The heart of the matter: THE SHADOW ALISKERIN WAR Secondly, we also learnt that Aliskerin can raise Plasma Renin level. What effect this will have, will require much more work, and more clinical trial
Combined Renin Inhibition/Beta-Blockade - Full Text View Sponsored by: The Rogosin Institute. Information provided by: The Rogosin Institute. ClinicalTrials.gov Identifier: NCT00627861
Blackwell Synergy - J Clin Hypertension, Volume 9 Issue 4 Page 297 The 3 open-label prospective randomized clinical trials had included men and In the ACE inhibitor/aliskerin study, subjects were started on ramipril 5
Current Opinion in Nephrology and Hypertension - Fulltext: Volume Aliskiren is the first in class DRI to be approved for clinical use. .. 41 ALiskerin Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease
Bioorganic & Medicinal Chemistry : Rational design of 6- 2,4 4c and 7 Aliskerin was recently approved by the FDA for the treatment on the 4-aryl-piperidine scaffold have recently entered human clinical trials,
A n a l y s i s o f R e c e n t P a p e r s i n H Your browser may not have a PDF reader available. Google recommends visiting our text version of this document.
In the ARB/aliskiren study, the addition of aliskerin. 150 mg daily to irbesartan 150 mg daily .. in most large clinical trials . If more office BP mea-
The Incidence and Implications of Aldosterone Breakthrough Only prospective, sufficiently-powered clinical trials that identify 36,37 In a study of 18 healthy volunteers given the renin inhibitor aliskerin,
INNA Ireland Such benefits are largely attributed to randomised controlled trials from which there is no Here the addition of aliskerin, the new renin inhibitor,
RxNews® Newsletter: Pipeline - RxSolutions.com Pfizer& 39;s torcetrapib/atorvastatin development program is the largest and most comprehensive clinical trial program the company has ever undertaken and is
Top Pharma/Biopharma Therapeutic Innovations of 2007 | Pharma& 39;s Dec 11, 2007 Eculizumab represents a tremendous clinical advance for PNH and Aliskerin, the first approved renin inhibitor, is probably best known
First-in-class diabetic drug to make market impact All this is set to change as Palosuran, currently in clinical development Aliskerin is an orally active renin inhibitor in development for the treatment
Nature Clinical Practice Nephrology | The incidence and In clinical trials of ACE inhibitors and ARBs, plasma aldosterone levels, . 37 In a study of 18 healthy volunteers given the renin inhibitor aliskerin,
